CD4 and breast cancer: A ‘triculture’ setup of the PyMT-derived organoids, CD4+ T effector cells directly derived from PyMT mammary tumors and TAMs without exogenous stimulation revealed the M2-like TAM phenotype was promoted by higher IL-4 expression in CD4+ T cells.